VYTRUS BIOTECH EO -01 (V5P) — Cash Flow-to-Debt Ratio
VYTRUS BIOTECH EO -01 (V5P) has a Cash Flow-to-Debt Ratio of 0.90x as of December 2025, meaning its operating cash flow of €3.90 Million could theoretically repay 1% of its total liabilities (€4.35 Million) in one year. See V5P cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
VYTRUS BIOTECH EO -01 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for VYTRUS BIOTECH EO -01 across 5 annual periods. Also explore net asset growth rate of VYTRUS BIOTECH EO -01 to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for VYTRUS BIOTECH EO -01 (2021–2025)
Year-by-year debt coverage analysis for VYTRUS BIOTECH EO -01. For market capitalisation and broader financial context, see VYTRUS BIOTECH EO -01 (V5P) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.90x | €3.90 Million | €4.35 Million | ▲ +86.5% |
| 2024 | 0.48x | €1.84 Million | €3.84 Million | ▲ +113.6% |
| 2023 | 0.22x | €904.39K | €4.02 Million | ▼ -28.8% |
| 2022 | 0.32x | €1.03 Million | €3.25 Million | ▲ +106.6% |
| 2021 | 0.15x | €447.92K | €2.93 Million | — |